Global Next Generation DNA Sequencing (NGS) Market – Industry Trends and Forecast to 2029

Global Next Generation DNA Sequencing (NGS) Market, By Product (Instruments, Consumables, Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical and Biotechnology Companies, Research Centers and Academic and Government Institutes, Hospital and Clinics) – Industry Trends and Forecast to 2029.

Global Next Generation DNA Sequencing (NGS) Market Analysis and Size

In recent years, the next generation DNA sequencing (NGS) market is anticipated to grow rapidly during the forecast period owing to the high prevalence rate of cancer. Next-generation sequencing is a DNA sequencing method that determines the exact arrangement of nucleotides within a DNA molecule. A million DNA molecules and RNA sequences are generated every second by the next-generation sequencer, enabling for rapid sequencing. Next-generation sequencing refers to high-throughput sequencing (NSG).

• Data Bridge Market Research analyses that the next generation DNA sequencing (NGS) market was valued at USD 9.4 billion in 2021 and is expected to reach USD 40.42 billion by 2029, registering a CAGR of 20% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Next Generation DNA Sequencing (NGS) Market Definition

The method of determining the sequence of nucleotides in a piece of DNA is known as next-generation sequencing, or high-throughput sequencing. Sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing, and single-molecule real-time (SMRT) sequencing are some of the techniques used. It is a cost-effective solution that provides precise, high-accuracy, and fast outcomes.

Report Scope and Market Segmentation

Next Generation DNA Sequencing (NGS) Market Dynamics

Drivers

• Increasing Prevalence of Chronic Diseases

The rising prevalence of chronic diseases such as cancer will propel the market’s growth rate during the forecast period of 2022-2029. There has been a tremendous growth in the use of NGS technology as a result of the widespread acceptance of liquid biopsies in cancer diagnoses. Cell-free circulating tumor DNA (ctDNA) is used as a non-invasive cancer biomarker for real-time cancer monitoring and detection in these technologies.

• Rise in the Adoption of Genome Mapping Programs

The market is also benefiting from the growing use of genomic mapping programmes to anticipate the development of various diseases. Scientists utilize genetic maps to help them figure out which genes are linked to rising rates of diabetes, heart disease, asthma, cancer, and psychiatric disorders.

Furthermore, the growing geriatric population will act as major factor influencing the growth of next generation DNA sequencing (NGS) market. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the next generation DNA sequencing (NGS) market. Also, increasing expenditure on healthcare infrastructure and rising use of NGS technology by pharmaceutical and biopharmaceutical companies are the major market drivers that will further escalate the growth of next generation DNA sequencing (NGS) market.

Opportunities

• Increase in the Number of Research and Development Activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities in the field of molecular biology, sequencing chemistry and technical engineering. This will provide beneficial opportunities for the next generation DNA sequencing (NGS) market growth.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the next generation DNA sequencing (NGS) market growth during the forecast period.

Restraints/Challenges Global Next Generation DNA Sequencing (NGS) Market

On the other hand, the high cost associated with next generation DNA sequencing (NGS) will obstruct the growth rate of market. The dearth of skilled professionals and rising risk of infection will challenge the next generation DNA sequencing (NGS) market. Additionally, impact of COVID-19 on supply chain and introduction of alternative technology will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This next generation DNA sequencing (NGS) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the next generation DNA sequencing (NGS) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Next Generation DNA Sequencing (NGS) Market

The dissemination use COVID-19 had a huge impact on numerous sectors around the world; the primary goal was to alleviate the global crisis. Pharmaceutical and biopharmaceutical industries, on the other hand, have grown tremendously as a result of pandemics. During the outbreak, developing self-test kits, therapies, and vaccinations were considered critical operations. As a result, various startups and established market players have raised their investments to support the process, assisting the next generation sequencing industry's overall growth. As a result, governmental entities have increased their research and development efforts in the next generation sequencing sector. The need of continuous supply and research was recognized by market participants, who boosted their investments in the industry as a result of the pandemic, resulting in higher Next Generation Sequencing market growth. 

Recent Development

• In January 2021, The Thalassemia Gene Detection Kit (Combinatorial Probe-Anchor Synthesis Sequencing Method) from BGI Group had acquired CE mark approval for genetic diagnosis of á, â thalassemia and other hemoglobinopathies, as well as general population carrier screening.

Global Next Generation DNA Sequencing (NGS) Market Scope

The next generation DNA sequencing (NGS) market is segmented on the basis of product, applications and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Instruments
• Consumables
• Services

Based on product, next generation DNA sequencing (NGS) market is segmented into instruments, consumables, and services.

Applications

• Diagnostics
• Biomarker Discovery
• Precision Medicine
• Drug Discovery
• Agriculture and Animal Research
• Others

On the basis of application, next generation DNA sequencing (NGS) market is segmented into diagnostics, biomarker discovery, precision medicine, drug discovery, agriculture and animal research and others.

End User

• Pharmaceutical and Biotechnology Companies
• Research Centers and Academic
• Government Institutes
• Hospital and Clinics

Next generation DNA sequencing (NGS) market has also been segmented based on the end user into pharmaceutical and biotechnology companies, research centers and academic and government institutes, hospital and clinics.

Next Generation DNA Sequencing (NGS) Market Regional Analysis/Insights

The next generation DNA sequencing (NGS) market is analysed and market size insights and trends are provided by country, product, applications and end user as referenced above.

The countries covered in the next generation DNA sequencing (NGS) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the next generation DNA sequencing (NGS) market because of the well-established healthcare infrastructure and increasing awareness about advanced treatment methods in this region. Additionally, presence of major key players will flourish the market’s growth rate in this region. 

Asia-Pacific is expected to grow during the forecast period due to rising prevalence of genetic diseases and growing awareness on reproductive health in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The next generation DNA sequencing (NGS) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for next generation DNA sequencing (NGS) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the next generation DNA sequencing (NGS) market. The data is available for historic period 2010-2020.

Competitive Landscape and Next Generation DNA Sequencing (NGS) Market Share Analysis

The Next generation DNA sequencing (NGS) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to next generation DNA sequencing (NGS) market.

Some of the major players operating in the next generation DNA sequencing (NGS) market are:

• Illumina, Inc. (US)
• Thermo Fisher Scientific Inc. (US)
• PerkinElmer, Inc. (US)
• BGI Group (China)
• Agilent Technologies, Inc. (US)
• Eurofins Scientific (Luxembourg)
• PacBio (US)
• Oxford Nanopore Technologies plc (UK)
• QIAGEN (Netherlands)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• GENEWIZ Inc. (US)
• Psomagen (South Korea)
• 10x Genomics (US)
• Takara Bio Inc (Japan)
• Bio-Rad Laboratories, Inc. (US)
• Zymo Research Corporation (US)
• Tecan Trading AG (Switzerland)
• Hamilton Company (US)
• Beckman Coulter, Inc. (US)
• BD (US)
• Lucigen Corporation (US)
• Novogene Co., Ltd. (China)